Featured Articles

Features
Pharmaceuticals are not only regulated by traditional pharmaceutical legislation but are also increasingly influenced by related environmental and stewardship laws. Extended producer responsibility (EPR) is reshaping the pharmaceutical industry with regulatory burdens, challenges, and strategic opportunities.
Features

Sustainability principles can be effectively integrated into commissioning and qualification (C&Q) projects to support environmental goals without compromising compliance, quality, or patient safety. By positioning C&Q as both a verification tool and an enabler of sustainable intent, this article outlines a practical path for the pharmaceutical sector to enhance operational efficiency,...

Features

The development of platform drug delivery devices for combination products offers a transformative approach to drug delivery by enabling the reuse of device data across multiple drug and device combinations.

Technical
Containment systems are essential in pharmaceutical manufacturing, ensuring product quality and protecting worker safety. They prevent cross-contamination, reduce occupational exposure to potent compounds, and support compliance with global Good Manufacturing Practice (GMP) standards. As manufacturing evolves, robust and adaptable containment strategies are increasingly vital for maintaining...
InTouch

Michelle Vuolo is currently Head of Quality at Tulip Interfaces, Inc., a platform developer that enables manufacturers of many industries to build digital content to manage their operations. Before joining Tulip, Michelle spent more than 24 years in the biopharmaceutical and medical devices industries in quality control (QC) laboratories, engineering technical support, quality assurance...

InTouch

Stephanie Stärkle is a project engineer at VTU Engineering in Switzerland, where she leads engineering projects from concept to execution in GMP-regulated environments including cost estimation, equipment design and specification, deadline management, and coordination with cross-functional stakeholders such as vendors, quality assurance, operations, and qualification. She holds a bachelor’s...

InTouch
There are everyday examples of climate impacts—an unexpected storm that creates flash flooding, extremely high temperatures for more days than normal, and longer droughts. According to the World Health Organization, if the climate continues changing at the same rate, it is expected to cause approximately 250,000 additional deaths per year, with direct damage costs of between US $2–$4 billion.
Insights

When I began my career as an engineer in a major pharmaceutical company, I worked in an engineering department filled with highly experienced senior engineers. I admired their depth of knowledge and the way they had accumulated a wealth of practical information over decades. Their grasp of systems, processes, and equipment was impressive and humbling. I found myself anxious to build that same...

Online Exclusives
Over the past decade, Advanced Therapy Medicinal Products (ATMPs) have introduced a significant shift to pharmaceutical manufacturing, introducing a new generation of personalized medicines that demonstrate promising results for diseases with few or no treatment options. In the United States, approximately 34,000 patients have received CAR T-cell therapies since 2024. With 17 authorized products...
Features

Advancements in technology—such as process intensification, continuous manufacturing, and 3D printing—are enabling transportable and point-of-care (PoC) medicines manufacturing, especially with the rise of personalized medicine. Modular, small-scale production systems are particularly well-suited for cell and gene therapies and other advanced therapy medicinal products (ATMPs) designed for...

Features

Simplified approaches that enable changes to analytical procedures over their lifecycle are needed to allow continual improvements and adaptations due to technological obsolescence and other challenges. This article reflects on the positive impact that the recent ICH Q14 guidance can have on facilitating these changes. Five examples are provided that are based on scenarios in which analytical...

Features

The International Council for Harmonisation (ICH) Q2(R2) and Q14 guidelines, finalized in late 2023, outline strategies for analytical procedure development, validation, and lifecycle management. As global implementation progresses, ISPE’s PQLI® Analytical Method Strategy Team surveyed industry stakeholders in mid-2024 to assess readiness, identify opportunities, and highlight areas...

Features

In April 2023, ISPE launched a survey to understand the sources of barriers to technological innovation within the pharmaceutical industry. This survey is part of an expansive and significant initiative by ISPE, Enabling Global Pharma Innovation: Delivering for Patients, which aims to promote consistent and harmonized interpretation and implementation of guidelines issued by the International...

Features

Defining requirements for calibration and routine testing of weighing equipment in the laboratory and production remains a complex endeavor for pharmaceutical companies. Applying sound, risk-based metrological strategies across the entire pharmaceutical value chain will help manufacturers ensure compliance, consumer safety, and commercial success.

Features

The United States Pharmacopeia (USP) Packaging and Distribution Expert Committee approved chapters 665 and 1665 in 2024. These chapters establish clear and general guidelines for the use of plastic materials in process equipment used within the pharmaceutical and biotechnology industries. Their publication has raised new questions regarding the role of polymeric materials in manufacturing...

Features

The increasing digitalization of the pharmaceutical and medical device industry has created novel cybersecurity challenges, particularly with the rapid advancement of artificial intelligence (AI) technologies. This article examines the dual nature of AI as both a potential threat vector and a powerful defensive tool.

Features

The move to digital transformation represents a true paradigm shift in manufacturing, enabling organizations to leverage advanced technologies such as the Industrial Internet of Things (IIoT), cloud computing, and artificial intelligence (AI) to ensure compliance and secure a competitive advantage. This article presents a working definition of digital transformation, the components involved in...

Features

Pharmaceutical companies can use digital maturity assessments to address the challenges of upgrading brownfield facilities and implementing digital transformation improvements. Enabled by stakeholder workshops, these assessments can rapidly produce concrete plans and priorities to guide a facility’s development over the next three to five years—delivering business value and laying the...

Features
The complex transformation toward Pharma 4.0™ requires comprehensive skill management. This case study builds on a previously presented framework and follows the fictional company NewCo as it tackles the challenge of developing a future-ready workforce during a plant expansion project. Guided by the framework, NewCo first establishes skill management governance and a cross-functional team. It...
Features

Pharma 4.0™ is a reference framework tailored to the pharmaceutical industry, guiding its digital transformation. Although many of today’s processes generate sufficient data to enable advanced use cases, structured guidance for transformation is often lacking. To address this, the ISPE Pharma 4.0™ Subcommittee on Process Data Maps and Critical Thinking has introduced an approach to help...

Features

The often-overlooked function of chemistry, manufacturing, and controls (CMC) holds tremendous potential to reshape the landscape of drug development. By embracing innovation and rethinking traditional approaches, CMC has the rare opportunity to drive transformative changes that could significantly accelerate the journey from initial concept to a fully realized therapy. This offers the...

Explore

White Paper
The life science validation sector is evolving with a focus on risk-based methodologies and increased access to digital data, driving innovation. The rise of Digital Validation Tools (DVTs) reflects the industry's emphasis on data integrity and principles of Pharma 4.0 and Validation 4.0. These advancements streamline monitoring and provide real-time insights into validated statuses through...
White Paper

Currently, there is no single guidance document providing a comprehensive roadmap for executing digital validation. While elements from ISPE GAMP® Guides Series and the ISPE Baseline® Guide: Volume 8 – Pharma 4.0™, apply to digital validation, there is no consolidated resource addressing common questions. The authors of this Concept Paper therefore advocate for the development of a Good...

Latest Articles

iSpeak Blog
The 2025 ISPE International Honor Awards were hosted in Charlotte, North Carolina, USA during the 2025 ISPE Annual Meeting & Expo. The ceremony, which took place at the Membership Meeting and Awards Lunch, recognized ISPE members and contributors whose dedication and service exemplify what it means to Shape the Future of Pharma™. The Max Seales Yonker Member of the Year Award was presented to...
iSpeak Blog

As industries across the globe navigate increasing complexity, consumer expectations, and regulatory pressures, the traditional boundaries of quality management are being pushed. Quality is no longer just a post-production checkpoint—it has become a strategic pillar that spans the entire product lifecycle. In this transformative landscape, artificial intelligence (AI) is emerging as a powerful...

iSpeak Blog

C&Q forms a critical connection between the construction phase and operational readiness of pharmaceutical manufacturing facilities. Despite C&Q’s important role in regulatory compliance, many project leaders are not prioritizing this phase, treating it as optional, low value added, or merely a paperwork exercise. This situation can exist in engineering, procurements, and construction...

InTouch

In each issue of Pharmaceutical Engineering®, we introduce a member of the ISPE staff who provides ISPE members with key information and services. Meet Eric Brown, Digital Developer in the Professional Development Department.

InTouch

With nearly 2,000 drugs currently in shortage across the UK—a staggering increase from 1,608 just one year prior—the pharmaceutical industry faces an unprecedented crisis that demands immediate attention.

InTouch

The rapid pace of digital innovation, offers plenty of unprecedented opportunities as well as a few unforeseen challenges. The ISPE Pharma 4.0™ Conference has been helping life science industry professionals embrace opportunities and overcome challenges since 2017. This year’s conference is no exception. We’ll examine EU GMP Chapter 4 Annex 11 and Annex 22’s new focus on emerging technologies...

Insights

In the heart of traditional Chinese kitchens lies a profound respect for resources: nothing is wasted, and simple ingredients and different flavors are combined to achieve a well-balanced meal through a defined process with suitable tools. What does ancient cuisine and modern pharmaceutical production have in common? And what could we learn in terms of sustainability?

iSpeak Blog
Cleanroom garments are worn by operators working in certified cleanrooms to protect the product and the processes inside the cleanroom from human sourced contamination and to maintain the integrity of the cleanroom. Selection and correct use of these garments has a significant impact on the performance of the cleanroom, an appropriate selection allows the use of lower air change rates as the...
iSpeak Blog
Members of the ISPE CaSA Chapter reviewed membership demographics at their annual kick-off meeting in August. The findings revealed that most members are industry professionals, with few student members, despite the many great universities in the Southeast US.
iSpeak Blog

Continuous manufacturing (CM) of oral solid dosage forms has become a well-established approach that offers multiple benefits in the production of pharmaceutical oral solid dosage forms as compared to traditional batch manufacturing. CM continues to offer opportunities for faster development and time to market, enhanced process robustness, improved quality assurance, and greater operational...

iSpeak Blog

The pharmaceutical industry is under constant pressure to expand capacity, accelerate time-to-market, and ensure reliable access to critical medicines. As more therapies gain regulatory approval and blockbuster drugs scale rapidly, the need for smarter, more resilient facilities has never been greater. That is why ISPE is particularly excited about the Innovative Facility Design track at the...

iSpeak Blog

The pace of innovation—digital joined with operational excellence—in the life sciences industry shows signs of improvement. Artificial intelligence, robotics, advanced analytics, smart facilities design and innovation culture are no longer “future concepts”—they are deeply transforming pharmaceutical development, manufacturing and the whole supply chain. Alongside many exciting opportunities...

iSpeak Blog

Advanced therapy medicinal products (ATMPs) represent a revolutionary frontier in medicine, offering life-changing treatments for conditions previously deemed incurable. However, the intricate nature of these therapies, from their unique raw materials to complex manufacturing and logistics, presents significant challenges and inherent risks including how to best develop validation methods and...

iSpeak Blog

This year’s ISPE Germany/Austria/Switzerland (D/A/CH) Affiliate workshop, “Pharma’s Journey to Digital Manufacturing and Supply,” united pharma leaders, technology experts and regulatory agencies for three days of intense exchanges on the digital transformation of our industry. Its innovative, highly interactive format enabled all 130 participants to engage, contribute, and learn from each...

iSpeak Blog
In a field defined by innovation, regulation, and rapid change, personal transformation can be just as vital as technical advancement. The Women in Pharma® community recognizes that today’s professionals face challenges not only in the lab or on the manufacturing floor, but also within themselves—especially when it comes to career reinvention, self-doubt, and visibility. That’s why “From Imposter...
iSpeak Blog

Bayer, a global leader in the pharmaceutical industry, is committed to advancing healthcare through innovative solutions. With their new Cell Therapy Launch and Manufacturing Facility, Bayer aims to provide hope to patients with unmet medical needs by finding a cure and making life-changing therapies more accessible to all. The facility signifies a major advancement in the production and...

Current Issue

November / December 2025

In This Issue: We dive into sustainable practices in the pharma industry and effective ways to safely implement them.